Literature DB >> 2052748

Fluxes and accumulation of tetracyclines by human blood cells.

W L Gabler1.   

Abstract

Tetracyclines (Tc's) have anti-inflammatory properties unrelated to their antibiotic activities. Their anti-inflammatory property, in part, results from the ability of members of this family of antibiotic to inhibit neutrophil functions. There are marked differences in the ability of different Tc's to suppress neutrophils which may relate to their ability to cross the plasma membrane. To gain insight into the mechanism of Tc inhibition of neutrophils and the reason for the differences in antineutrophil effect of Tc's, we studied the flux and sequestration of Tc's in blood cells. Using centrifugation and a dibutylphthalate scrubber system we found that doxycycline (Dc) was rapidly taken up by blood cells reaching intracellular concentrations several times that found in the medium. Dc also rapidly effluxed when antibiotic loaded cells were placed in drug free medium. While Ca2+, Mg2+ nor protein separately were effective inhibitors of Dc influx, when divalent cations and proteins were combined Dc uptake was markedly suppressed. Tc uptake by blood cells ranked Dc greater than chlortetracycline = tetracycline greater than oxytetracycline, a ranking similar to that reported for neutrophil inhibition by members of the Tc family, suggesting that intracellular accumulation of drug is an important facet of Tc suppression of neutrophil function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052748

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  14 in total

1.  Accumulation of ciprofloxacin and minocycline by cultured human gingival fibroblasts.

Authors:  Q Yang; R J Nakkula; J D Walters
Journal:  J Dent Res       Date:  2002-12       Impact factor: 6.116

Review 2.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects.

Authors:  Gopal Muralidharan; Marlynne Micalizzi; John Speth; Donald Raible; Steven Troy
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Characterization of minocycline transport by human neutrophils.

Authors:  John D Walters
Journal:  J Periodontol       Date:  2006-12       Impact factor: 6.993

5.  An in vitro model of ciprofloxacin and minocycline transport by oral epithelial cells.

Authors:  James J Brayton; Qing Yang; Robin J Nakkula; John D Walters
Journal:  J Periodontol       Date:  2002-11       Impact factor: 6.993

6.  A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge.

Authors:  J B Wingard; E G Romanowski; R P Kowalski; F S Mah; Y Ling; R A Bilonick; R M Q Shanks
Journal:  Antimicrob Agents Chemother       Date:  2011-05-31       Impact factor: 5.191

7.  Susceptibilities of Legionella spp. to newer antimicrobials in vitro.

Authors:  T Schülin; C B Wennersten; M J Ferraro; R C Moellering; G M Eliopoulos
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

8.  Doxycycline reduction of F-actin content of human neutrophils and fibroblasts.

Authors:  W L Gabler; J Smith; N Tsukuda
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

9.  The influence of tetracyclines on T cell activation.

Authors:  M Kloppenburg; C L Verweij; A M Miltenburg; A J Verhoeven; M R Daha; B A Dijkmans; F C Breedveld
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

Review 10.  Clinical pharmacokinetics and pharmacodynamics of tigecycline.

Authors:  April Barbour; Stephan Schmidt; Benjamin Ma; Lars Schiefelbein; Kenneth H Rand; Olaf Burkhardt; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.